Honokiol treatment inhibited FAK phosphorylation in breast cancer cells, indicating the involvement of FAK activation in honokiol-mediated inhibition of migration and invasion potential of breast cancer cells (Figure 2d). The gene discussed is PTK2; the disease is breast carcinoma.